Archive for Volume 2 Issue 1
Medication Non-Adherence and the Public Opinion Problem
The adherence problem is finally evolving from the biggest problem in healthcare you probably didn’t know about, to one [...]
Read More →The HCPC Alliance Awards Innovative Packaging for Better Patient Compliance
Over the last years the lament of the pharma industry over the lack of new blockbuster drugs has become [...]
Read More →
The Role of Co-Pay Card Programmes in Medication Adherence
In countries where cost is not an issue given socialised medicine, the overall adherence rate is not much better [...]
Read More →An Expert Viewpoint: Building an Adherence Trust Pathway
While electronic monitoring of patients’ medicines adherence is becoming standard practice in clinical trials involving chronic diseases, most patients [...]
Read More →
Packaging & Patient Adherence
There have been a number of exciting developments in the areas of leading-edge Drug Delivery, Drug Packaging, and Labelling [...]
Read More →
Chronic Respiratory Diseases and their Challenges
The WHO estimates that hundreds of millions of people suffer every day from chronic respiratory diseases. Their last estimate [...]
Read More →
Patient Communities: The Future of Adherence?
Pharma companies will succeed or fail based not on how much drug they sell, but on how well their [...]
Read More →Evolving US Safety Regulations and Risk Management Programmes
The US Risk Evaluation and Mitigation Strategies (REMS) requirements for a drug or drug class are continuously evolving. The [...]
Read More →
Patient Advocacy: Compliance from the Patient’s Point of View
Frequently patients go through a medical crisis or event which causes them to require medication. Many physicians, clinicians and [...]
Read More →Dentist Murray Hawkins talks about Dental Anxiety
The dental industry and profession is renowned for its innovation in materials science, equipment design and advancement of technique. [...]
Read More →
IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.
Journal for Clinical Studies (JCS) is a peer reviewed journal which details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within emerging markets, naïve patient population and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas prevalent in emerging market areas.
